Xuewei Xie1,2,3,4, Xianwei Wang1,2,3,4, Zixiao Li1,2,3,4, Xingquan Zhao1,2,3,4, Zhongrong Miao1,2,3,4,5, Liping Liu1,2,3,4, Hao Li1,2,3,4, Xia Meng1,2,3,4, Yongjun Wang1,2,3,4, Yilong Wang1,2,3,4. 1. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University. 2. China National Clinical Research Center for Neurological Diseases. 3. Center of Stroke, Beijing Institute for Brain Disorders. 4. Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease Beijing. 5. Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University.
Abstract
AIM: The impact of international normalized ratio (INR) on prognosis after acute ischemic stroke without anticoagulation therapy is unclear. Herein, the association between baseline INR and stroke outcomes in patients without anticoagulation therapy was investigated. METHODS: A total of 14,782 ischemic stroke patients from the China National Stroke Registry Ⅱ were included in this analysis. The period of follow-up was 1 year after stroke onset. Multivariate logistic regression models were used to estimate the relationship between INR and stroke outcomes including all-cause death, recurrent stroke, composite end point, and poor functional outcome. RESULTS: Of 14,782 patients with stroke, all-cause death occurred in 1080 (7.3%), recurrence stroke in 538 (3.9%), combined end point in 1319 (8.9%), and poor functional outcome in 3001 (20.3%). Compared with the medium INR group (0.9-1.1), the odds ratios with confidence intervals of 95% for the high INR group (＞1.1) were 1.58 (1.32-1.98) for all-cause death, 1.40 (1.10-1.79) for stroke recurrence, 1.52 (1.29-1.79) for combined end point, and 1.21 (1.06-1.39) for poor functional outcome. No association between low INR (＜0.9) and any stroke outcomes was found compared with the medium group. CONCLUSIONS: Increased admission INR was associated with adverse stroke outcomes among acute ischemic stroke patients without atrial fibrillation or anticoagulation therapy.
AIM: The impact of international normalized ratio (INR) on prognosis after acute ischemic stroke without anticoagulation therapy is unclear. Herein, the association between baseline INR and stroke outcomes in patients without anticoagulation therapy was investigated. METHODS: A total of 14,782 ischemic strokepatients from the China National Stroke Registry Ⅱ were included in this analysis. The period of follow-up was 1 year after stroke onset. Multivariate logistic regression models were used to estimate the relationship between INR and stroke outcomes including all-cause death, recurrent stroke, composite end point, and poor functional outcome. RESULTS: Of 14,782 patients with stroke, all-cause death occurred in 1080 (7.3%), recurrence stroke in 538 (3.9%), combined end point in 1319 (8.9%), and poor functional outcome in 3001 (20.3%). Compared with the medium INR group (0.9-1.1), the odds ratios with confidence intervals of 95% for the high INR group (＞1.1) were 1.58 (1.32-1.98) for all-cause death, 1.40 (1.10-1.79) for stroke recurrence, 1.52 (1.29-1.79) for combined end point, and 1.21 (1.06-1.39) for poor functional outcome. No association between low INR (＜0.9) and any stroke outcomes was found compared with the medium group. CONCLUSIONS: Increased admission INR was associated with adverse stroke outcomes among acute ischemic strokepatients without atrial fibrillation or anticoagulation therapy.
Entities:
Keywords:
International normalized ratio; Minor stroke; Recurrent stroke; Registries; Transient ischemic attack
Authors: Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale Journal: Circulation Date: 2007-11-12 Impact factor: 29.690
Authors: Hakan Ay; Ethem Murat Arsava; Levent Gungor; David Greer; Aneesh B Singhal; Karen L Furie; Walter J Koroshetz; A Gregory Sorensen Journal: Ann Neurol Date: 2008-11 Impact factor: 10.422
Authors: Edward C Jauch; Jeffrey L Saver; Harold P Adams; Askiel Bruno; J J Buddy Connors; Bart M Demaerschalk; Pooja Khatri; Paul W McMullan; Adnan I Qureshi; Kenneth Rosenfield; Phillip A Scott; Debbie R Summers; David Z Wang; Max Wintermark; Howard Yonas Journal: Stroke Date: 2013-01-31 Impact factor: 7.914
Authors: Alan S Go; Elaine M Hylek; Yuchiao Chang; Kathleen A Phillips; Lori E Henault; Angela M Capra; Nancy G Jensvold; Joe V Selby; Daniel E Singer Journal: JAMA Date: 2003-11-26 Impact factor: 56.272